 "An Abbott company logo is pictured at the reception of its office in Mumbai")
Abbott, market leader in premium cardiac stents, may withdraw its products from India following the National Pharmaceutical Pricing Authority’s (NPPA’s) order to cap prices last week.
NPPA set a price cap of Rs 7,260 on bare metal stents and Rs 29,600 on drug eluting and biodegradable ones.
“Abbott may withdraw its Xience Alpine and its dissolving stent, Absorb,” said a distributor on the basis of informal communication. Abbott’s dissolving stent was priced at a little less than Rs 2 lakh before the price cap and the import price was Rs 42,125.
"Abbott does not comment on market speculation," said a
